ENTSOG CMP Monitoring Report 2016

4 Results of Effect Monitoring Exercise

INDICATOR 1 (CMP.1): ADDITIONAL CAPACITY VOLUMES MADE AVAILABLE THROUGH EACH CMP

As shown in Figure 1, FDA UIOLI is the CMP mechanism that releases the most capacity – on a cumulative basis for the period under consid- eration – at congested IPs while the LT UIOLI mechanism does not provide any additional ca- pacity at congested IP sides to the market for the observed period. The capacity volume released through OS+BB is moderate in comparison with FDA UIOLI and Surrender of Capacity.

Surrender of Capacity appears to be the most ef- fective of all four CMPs for network users since the ratio of allocated capacity relative to capaci- ty on offer is close to 100%. This is due to the fact that Surrender of Capacity in the allocation process has, after available capacity, is first pri- ority for yearly, quarterly and monthly products.

OS + BB

FDA UIOLI

SURRENDER

LT UIOLI

ADDITIONAL CAPACITY OFFERED

16.396 MWh/h/y

679.346 MWh/h/y

100.541 MWh/h/y

–

(RE)ALLOCATED CAPACITY

–

2.344 MMWh/h/y

93.041 MWh/h/y

–

RATIO

0%

0.35%

92.54%

–

OS + BB: Oversubscription and Buy-Back

FDA UIOLI: Firm Day-Ahead Use-It-Or-Lose-It

SURRENDER: Surrender of Capacity

LT UIOLI: Long-Term Use-It-Or-Lose-It

CMP Offered and Allocated Capacity

679 346.10

700 000

600 000

500 000

400 000

300 000

200 000

100 541.20

93 040.82

100 000

16 395.68

–

2 344.21

–

–

0

OS + BB

FDA UIOLI

Surrender

LT UIOLI

Offered

Allocated

Figure 1: Results of CMP indicator 1

20 |

ENTSOG CMP Monitoring Report 2016